These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36383383)

  • 1. Safety of Withholding Perioperative Hydrocortisone for Patients With Pituitary Adenomas With an Intact Hypothalamus-Pituitary-Adrenal Axis: A Randomized Clinical Trial.
    Guo X; Zhang D; Pang H; Wang Z; Gao L; Wang Y; Ma W; Lian W; Xing B;
    JAMA Netw Open; 2022 Nov; 5(11):e2242221. PubMed ID: 36383383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of withholding hydrocortisone during preoperative periods in pituitary adenomas patients with an intact HPA axis: A meta-analysis of randomized controlled trials.
    Lin F; Su Y; Zhang X; Liang B; Qin M
    Neuro Endocrinol Lett; 2023 Jun; 44(3):131-139. PubMed ID: 37392440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withholding Perioperative Steroids in Patients Undergoing Transsphenoidal Resection for Pituitary Disease: Randomized Prospective Clinical Trial to Assess Safety.
    Sterl K; Thompson B; Goss CW; Dacey RG; Rich KM; Zipfel GJ; Chicoine MR; Kim AH; Silverstein JM
    Neurosurgery; 2019 Aug; 85(2):E226-E232. PubMed ID: 30325449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose ACTH test for evaluation of hypothalamus-pituitary-adrenal axis preoperatively and 3-month follow-up in non-functioning pituitary adenomas.
    Garg A; Mishra SK; Dubey S; Singh VP; Kuchay MS; Mithal A
    J Endocrinol Invest; 2020 Dec; 43(12):1769-1777. PubMed ID: 32436184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In pituitary adenoma surgery, no vs. perioperative hydrocortisone was noninferior for new-onset adrenal insufficiency.
    Gandhi GY
    Ann Intern Med; 2023 Apr; 176(4):JC46. PubMed ID: 37011395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cut-off values for sufficient cortisol response to low dose Short Synacthen Test after surgery for non-functioning pituitary adenoma.
    Kolnes AJ; Øystese KA; Dahlberg D; Berg-Johnsen J; Niehusmann P; Pahnke J; Bollerslev J; Jørgensen AP
    Acta Neurochir (Wien); 2020 Apr; 162(4):845-852. PubMed ID: 31907611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery of the Hypothalamo-Pituitary-Adrenal Axis After Transsphenoidal Adenomectomy for Non-ACTH-Secreting Macroadenomas.
    Pofi R; Gunatilake S; Macgregor V; Shine B; Joseph R; Grossman AB; Isidori AM; Cudlip S; Jafar-Mohammadi B; Tomlinson JW; Pal A
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5316-5324. PubMed ID: 31225871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the hypothalamic-pituitary-adrenal axis immediately after pituitary adenomectomy: is perioperative steroid therapy necessary?
    Hout WM; Arafah BM; Salazar R; Selman W
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1208-12. PubMed ID: 3372683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early morning cortisol levels as predictors of short-term and long-term adrenal function after endonasal transsphenoidal surgery for pituitary adenomas and Rathke's cleft cysts.
    McLaughlin N; Cohan P; Barnett P; Eisenberg A; Chaloner C; Kelly DF
    World Neurosurg; 2013 Nov; 80(5):569-75. PubMed ID: 22902358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative cortisol can predict hypothalamus-pituitary-adrenal status in clinically non-functioning pituitary adenomas.
    Cozzi R; Lasio G; Cardia A; Felisati G; Montini M; Attanasio R
    J Endocrinol Invest; 2009 May; 32(5):460-4. PubMed ID: 19494715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of morning serum cortisol level after transsphenoidal resection of pituitary adenoma to predict the need for long-term glucocorticoid supplementation.
    Marko NF; Gonugunta VA; Hamrahian AH; Usmani A; Mayberg MR; Weil RJ
    J Neurosurg; 2009 Sep; 111(3):540-4. PubMed ID: 19326985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective perioperative steroid supplementation protocol in patients undergoing endoscopic transsphenoidal surgery for pituitary adenomas.
    Chacko SR; Abraham AP; Asha HS; Kapoor N; Rajaratnam S; Chacko AG
    Acta Neurochir (Wien); 2020 Oct; 162(10):2381-2388. PubMed ID: 32772164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peri-operative glucocorticoid replacement therapy in transsphenoidal pituitary adenoma surgery: a prospective controlled study.
    Kristof RA; Wichers M; Haun D; Redel L; Klingmüller D; Schramm J
    Acta Neurochir (Wien); 2008 Apr; 150(4):329-35; discussion 335. PubMed ID: 18309452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intraoperative cortisol levels after preoperative hydrocortisone administration versus placebo in patients without adrenal insufficiency undergoing endoscopic transsphenoidal removal of nonfunctioning pituitary adenomas: a double-blind randomized trial.
    Lee HC; Yoon HK; Kim JH; Kim YH; Park HP
    J Neurosurg; 2021 Feb; 134(2):526-534. PubMed ID: 31978882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MORNING SERUM CORTISOL LEVEL AFTER TRANSSPHENOIDAL SURGERY FOR PITUITARY ADENOMA PREDICTS HYPOTHALAMIC-PITUITARY-ADRENAL FUNCTION DESPITE INTRAOPERATIVE DEXAMETHASONE USE.
    Manuylova E; Calvi LM; Vates GE; Hastings C; Shafiq I
    Endocr Pract; 2015 Aug; 21(8):897-902. PubMed ID: 26121454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immediate postoperative cortisol levels accurately predict postoperative hypothalamic-pituitary-adrenal axis function after transsphenoidal surgery for pituitary tumors.
    Marko NF; Hamrahian AH; Weil RJ
    Pituitary; 2010 Sep; 13(3):249-55. PubMed ID: 20339931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Basal Cortisol Level as a Predictor of Hypothalamic-Pituitary-Adrenal (HPA) Axis Function After Pituitary Tumor Surgery.
    Polovina TS; Kraljevic I; Solak M; Balasko A; Haxhiu A; Haxhiu A; Dusek T; Poljicanin T; Kastelan D
    Exp Clin Endocrinol Diabetes; 2020 Nov; 128(11):709-714. PubMed ID: 31091548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative management of the hypothalamic-pituitary-adrenal axis in patients with pituitary adenomas: an Australasian survey.
    Joseph SP; Ho JT; Doogue MP; Burt MG
    Intern Med J; 2012 Oct; 42(10):1120-4. PubMed ID: 21883779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UTILITY OF A GLUCOCORTICOID SPARING STRATEGY IN THE MANAGEMENT OF PATIENTS FOLLOWING TRANSSPHENOIDAL SURGERY.
    Jia X; Pendharkar AV; Loftus P; Dodd RL; Chu O; Fraenkel M; Katznelson L
    Endocr Pract; 2016 Sep; 22(9):1033-9. PubMed ID: 27124693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Day 5 morning serum cortisol predicts hypothalamic-pituitary-adrenal function after transsphenoidal surgery for pituitary tumors.
    Jayasena CN; Gadhvi KA; Gohel B; Martin NM; Mendoza N; Meeran K; Dhillo WS
    Clin Chem; 2009 May; 55(5):972-7. PubMed ID: 19282356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.